Overview

The most comprehensive, widely used, and evidence-based pharmacotherapy text available Full-color design! A Doody's Core Title ESSENTIAL PURCHASE for 2011! 5 STAR DOODYS'S REVIEW! ""This is a gold standard reference in pharmacy and the information it provides equips readers with the knowledge base and confidence to provide the highest quality of patient care.""--Doody's Review Service Hailed by Doody's Review Service as ""one of the best in pharmacy"" Pharmacotherapy: A Pathophysiologic Approach is unmatched in its ability to help students develop a mastery of evidence-based medicine for optimum patient outcomes. The eighth edition will feature the addition of SI units throughout and an increased number of global examples and clinical questions. Features Unparalleled guidance in the development of pharmaceutical care plansFull-color presentationKey Concepts in each chapterCritical Presentation boxes summarize common disease signs and symptomsClinical Controversies boxes examin complicated issues you face when providing drug therapyNEW material added to the online learning center EXPANDED evidence-based recommendations EXPANDED coverage of timely issues such as palliative care and pain medicine Therapeutic recommendations in each disease-specific chapter

Full Product Details

Author:   Joseph Dipiro ,  Robert Talbert ,  Gary Yee ,  Gary Matzke
Publisher:   McGraw-Hill Education - Europe
Imprint:   McGraw-Hill Medical
Edition:   8th edition
Dimensions:   Width: 22.40cm , Height: 7.70cm , Length: 28.50cm
Weight:   4.350kg
ISBN:  

9780071703543

ISBN 10:   0071703543
Pages:   2704
Publication Date:   16 April 2011
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Out of Print
Availability:   In Print  
Limited stock is available. It will be ordered for you and shipped pending supplier's limited stock.

Table of Contents

Section 1: Foundation IssuesSection Editor: L. Michael Posey 1.Pharmacoeconomics: Principles, Methods, and Applications 2.Health Outcomes and Quality of Life 3.Health Literacy and Medication Use 4.Cultural Competency 5.Principles and Practices of Medication Safety 6.Evidence Based Medicine 7.Documentation of Pharmacy Services 8.Clinical Pharmacokinetics and Pharmacodynamics 9.Pharmacogenetics 10.Pediatrics 11.Geriatrics 12.Palliative Care 13. Pharmacoepidemiology 14. Clinical Toxicology 15. Emergency Preparedness: Identification and Management of Biologic Exposures 16. Emergency Preparedness: Identification adn Management of Chemical and Radiologic Exposures Section 2: Cardiovascular DisordersSection Editor: Robert L. Talbert 17.Cardiovascular Testing 18.Cardiac Arrest 19.Hypertension 20.Systolic Heart Failure 21.Diastolic Heart Failure and the Cardiomyopathies 22.Acute Decompensated Heart 23.Ischemic Heart DiseaseJ 24.Acute Coronary Syndromes 25.The Arrhythmias 26. Venous Thromboembolism 27.Stroke 28.Dyslipidemia 29.Peripheral Arterial Disease 30.Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock 31.Hypovolemic Shock Section 3: Respiratory DisordersSection Editor: Robert L. Talbert 32.Introduction to Pulmonary Function Testing 33.Asthma 34.Chronic Obstructive Pulmonary Disease 35.Pulmonary Hypertension 36.Drug-Induced Pulmonary Diseases 37.Cystic Fibrosis Section 4: Gastrointestinal DisordersSection Editor: Joseph T. DiPiro 38.Evaluation of the Gastrointestinal Tract 39.Gastroesophageal Reflux Disease 40.Peptic Ulcer Disease 41.Inflammatory Bowel Disease 42.Nausea and Vomiting 43.Diarrhea, Constipation, and Irritable Bowel Syndrome 44.Portal Hypertension and Cirrhosis 45.Drug-Induced Liver Disease 46.Pancreatitis 47.Viral Hepatitis 48.Drug Therapy Individualization in Patients with Hepatic Disease or Genetic Alterations in Drug Metabolizing Activity 49. Celiac Disease Section 5: Renal DisordersSection Editor: Gary R. Matzke 50.Clinical Assessment of Kidney Function 51.Acute Kidney Injury 52.Chronic Kidney Disease: Progression-Modifying Therapies 53.Chronic Kidney Disease: Management of Complications 54.Hemodialysis and Peritoneal Dialysis 55.Drug-Induced Kidney Disease 56.Glomerulonephritis 57.Drug Therapy Individualization for Patients with Renal Insufficiency 58.Disorders of Sodium and Water Homeostasis 59.Disorders of Calcium and Phosphorus Homeostasis 60.Disorders of Potassium and Magnesium Homeostasis Donald F. Brophy and Todd W. B. Gehr 61.Acid-Base Disorders Section 6: Neurologic DisordersSection Editor: Barbara G. Wells 62.Evaluation of Neurologic Illness 63.Alheimer's Disease 64. Multiple Sclerosis 65. Epilepsy 66.Status Epilepticus 67.Acute Management of the Brain Injury Patient 68.Parkinson's Disease 69. Pain Management 70.Headache Disorders Section 7: Psychiatric DisordersSection Editor: Barbara G. Wells 71.Evaluation of Psychiatric Illness 72.Childhood Disorders 73.Eating Disorders 74.Substance Related Disroders: Overview and Depressahts, Stimulants and Hallucinogens 75.Substance-Related Disorders: Alcohol, Nicotine, and Caffeine 76.Schizophrenia 77.Major Depressive Disorders 78.Bipolar Disorder 79.Anxiety Disorders I: Generalized Anxiety, Panic, and Social Anxiety Disorders 80.Anxiety Disorders II: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder 81.Sleep Disorders 82.Disorders Associated with Intellectual Disabilities 83.Diabetes Mellitus 84.Thyroid Disorders 85.Adrenal Gland Disorders 86.Pituitary Gland Disorders Section 9: Gynecologic and Obstetric DisordersSection Editor: Barbara G. Wells 87.Pregnancy and Lactation: Therapeutic Considerations 88.Contraception 89.Menstruation-Related Disorders 90.Endometriosis 91. Hormone Terapy in Women Section 10: Urologic DisordersSection Editor: L. Michael Posey 92.Erectile Dysfunction 93.Benign Prostatic Hyperplasia 94.Urinary Incontinence Section 11: Immunologic DisordersSection Editor: Gary C. Yee 95. Function and Evaluation of the Immune System 96.Systemic Lupus Erythematosus and Other Collagen-Vascular Diseases 97.Allergic and Pseudoallergic Drug Reactions 98.Solid-Organ Transplantation Section 12: Rheumatologic DisordersSection Editor: L. Michael Posey 99Osteoporosis and Other Metabolic Bone Diseases 100.Rheumatoid Arthritis 101.Osteoarthritis 102. Gout and Hyperuricemia Section 13: Ophthalmic and Otolaryngological DisordersSection Editor: L. Michael Posey 103.Glaucoma 104.Allergic Rhinitis Section 14: Dermatologic DisordersSection Editor: L. Michael Posey 105Dermatologic Drug Reactions and Common Skin Conditions 106.Acne Vulgaris 107.Psoriasis 108.Atopic Dermatitis Section 15: Hematologic DisordersSection Editor: Gary C. Yee 109.Anemias 110.Coagulation Disorders 111. Sickle Cell Disease 112.Drug-Induced Hematologic Disorders Section 16: Infectious DiseasesSection Editor: Joseph T. DiPiro 113.Laboratory Tests to Direct Antimicrobial Pharmacotherapy 114.Antimicrobial Regimen Selection 115.Central Nervous System Infections 116.Lower Respiratory Tract Infections 117.Upper Respiratory Tract Infections 118.Influenza 119.Skin and Soft Tissue Infections 120.Infective Endocarditis 121.Tuberculosis 122.Gastrointestinal Infections and Enterotoxigenic Poisonings 123.Intraabdominal Infections 124.Parasitic Diseases 125.Urinary Tract Infections and Prostatitis 126.Sexually Transmitted Diseases 127.Bone and Joint Infections 128.Sepsis and Septic Shock 129.Superficial Fungal Infections 130.Invasive Fungal Infections 131.Infections in Immunocompromised Patients 132.Antimicrobial Prophylaxis in Surgery 133.Vaccines, Toxoids, and Other Immunobiologics 134.Human Immunodeficiency Virus Infection Section 17: Oncologic DisordersSection Editor: Gary C. Yee 135.Cancer Treatment and Chemotherapy 136.Breast Cancer 137.Lung Cancer 138.Colorectal Cancer 139.Prostate Cancer 140.Lymphomas 141.Ovarian Cancer 142.Acute Leukemias 143.Chronic Leukemias 144.Multiple Myeloma 145.Myelodysplastic Syndromes (Web-only) 146.Skin Cancer 147. Melanoma 148. Hematopoietic Stem Cell Transplantation Section 18: Nutritional DisordersSection Editor: Gary R. Matzke 149.Assessment of Nutrition Status and Nutrition Requirements 150.Medication Administration Considerations With Specialized Nutrition Support 151.Parenteral Nutrition 152.Enteral Nutrition 153.Nutritional Considerations in Major Organ Failure 154.Obesity Glossary Index

Reviews

Author Information

McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide L. Michael Posey, RPh, is president of Pharmacy Editorial & News Services (PENS) in Athens, Georgia, and an editor for the APhA periodicals Journal of the American Pharmacists Association, Pharmacy Today, and APhA DrugInfoLine. He also assists with drug information content for APhA’s cutting-edge Web site, www.pharmacist.com. During a career spanning two decades as a pharmacy communicator, Posey has served as editor of The Consultant Pharmacist and the American Journal of Hospital Pharmacy, and is an editor of the textbook Pharmacotherapy: A Pathophysiologic Approach.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions